Linda Härmark

2.0k total citations
59 papers, 1.4k citations indexed

About

Linda Härmark is a scholar working on Toxicology, Pharmacology and Pharmacology. According to data from OpenAlex, Linda Härmark has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Toxicology, 15 papers in Pharmacology and 15 papers in Pharmacology. Recurrent topics in Linda Härmark's work include Pharmacovigilance and Adverse Drug Reactions (40 papers), Drug-Induced Adverse Reactions (14 papers) and Pharmaceutical industry and healthcare (13 papers). Linda Härmark is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (40 papers), Drug-Induced Adverse Reactions (14 papers) and Pharmaceutical industry and healthcare (13 papers). Linda Härmark collaborates with scholars based in Netherlands, Sweden and New Zealand. Linda Härmark's co-authors include A.C. van Grootheest, Florence van Hunsel, Kees van Grootheest, Eugène van Puijenbroek, Birgitta Grundmark, Sten Olsson, Shanthi Pal, H.E. van der Wiel, Mark de Groot and Leàn Rolfes and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Vaccine.

In The Last Decade

Linda Härmark

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Härmark Netherlands 23 812 325 297 286 198 59 1.4k
Florence van Hunsel Netherlands 23 995 1.2× 405 1.2× 405 1.4× 387 1.4× 346 1.7× 122 1.8k
Shanthi Pal Switzerland 18 629 0.8× 268 0.8× 322 1.1× 191 0.7× 111 0.6× 33 1.3k
Kees van Grootheest Netherlands 23 1.1k 1.4× 487 1.5× 418 1.4× 326 1.1× 303 1.5× 40 1.5k
Judith A. Racoosin United States 15 344 0.4× 264 0.8× 231 0.8× 340 1.2× 107 0.5× 27 2.1k
Janet Sultana Italy 24 376 0.5× 265 0.8× 257 0.9× 242 0.8× 124 0.6× 77 2.1k
Tom Mjörndal Sweden 23 423 0.5× 325 1.0× 189 0.6× 236 0.8× 140 0.7× 59 2.0k
Lise Aagaard Denmark 17 383 0.5× 258 0.8× 154 0.5× 158 0.6× 87 0.4× 41 1.0k
Ronald D. Mann United Kingdom 25 302 0.4× 381 1.2× 147 0.5× 467 1.6× 146 0.7× 77 2.1k
Elliot G. Brown United Kingdom 5 494 0.6× 185 0.6× 103 0.3× 231 0.8× 113 0.6× 11 1.3k
Hitomi Teramachi Japan 16 294 0.4× 119 0.4× 109 0.4× 161 0.6× 231 1.2× 174 1.2k

Countries citing papers authored by Linda Härmark

Since Specialization
Citations

This map shows the geographic impact of Linda Härmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Härmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Härmark more than expected).

Fields of papers citing papers by Linda Härmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Härmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Härmark. The network helps show where Linda Härmark may publish in the future.

Co-authorship network of co-authors of Linda Härmark

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Härmark. A scholar is included among the top collaborators of Linda Härmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Härmark. Linda Härmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Härmark, Linda, et al.. (2024). Development, assessment and educational impact of a blended e-learning training program on pharmacovigilance implemented in four African countries. Frontiers in Medicine. 11. 1347317–1347317. 3 indexed citations
2.
Härmark, Linda, et al.. (2023). Natural language processing for automated triage and prioritization of individual case safety reports for case-by-case assessment. SHILAP Revista de lepidopterología. 3. 1120135–1120135. 2 indexed citations
3.
Vinkers, Christiaan H., et al.. (2022). Development and validation of a machine-learning algorithm to predict the relevance of scientific articles within the field of teratology. Reproductive Toxicology. 113. 150–154. 4 indexed citations
4.
Härmark, Linda, et al.. (2022). An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini. AIDS Research and Therapy. 19(1). 54–54. 6 indexed citations
5.
Isah, Ambrose O., Alexander Kay, Blandina T. Mmbaga, et al.. (2021). Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis. BMC Health Services Research. 21(1). 1062–1062. 5 indexed citations
6.
7.
Härmark, Linda, et al.. (2020). Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands. Drug Safety. 43(8). 745–749. 4 indexed citations
8.
Pierce, Carrie E., Sieta T. de Vries, Linda Härmark, et al.. (2019). Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. Drug Safety. 42(4). 477–489. 42 indexed citations
9.
Härmark, Linda, et al.. (2019). Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana. Ghana Medical Journal. 53(2). 150–150. 5 indexed citations
10.
Watson, Sarah, Rebecca E. Chandler, H. Taavola, et al.. (2017). Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. Drug Safety. 41(2). 203–212. 36 indexed citations
11.
Härmark, Linda, et al.. (2016). Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory Landscape. Therapeutic Innovation & Regulatory Science. 51(1). 125–131. 8 indexed citations
12.
13.
Kant, A., et al.. (2015). Web-based intensive monitoring of adverse events following influenza vaccination in general practice. Vaccine. 33(19). 2283–2288. 14 indexed citations
14.
Gaalen, Judith van, et al.. (2014). Drug-Induced Cerebellar Ataxia: A Systematic Review. CNS Drugs. 28(12). 1139–1153. 44 indexed citations
15.
Harrison‐Woolrych, Mira, Linda Härmark, Ming Tan, Simran Maggo, & Kees van Grootheest. (2012). Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres. European Journal of Clinical Pharmacology. 68(7). 1065–1072.
16.
Hunsel, Florence van, Linda Härmark, Shanthi Pal, Sten Olsson, & Kees van Grootheest. (2011). Experiences with Adverse Drug Reaction Reporting by Patients. Drug Safety. 35(1). 45–60. 113 indexed citations
17.
Heus, Roel de, Ben W. Mol, J.J.H.M. Erwich, et al.. (2009). Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 338(mar05 2). b744–b744. 84 indexed citations
18.
Härmark, Linda, H.E. van der Wiel, Mark de Groot, & A.C. van Grootheest. (2007). Proton pump inhibitor‐induced acute interstitial nephritis. British Journal of Clinical Pharmacology. 64(6). 819–823. 80 indexed citations
19.
Bermel, Christina, Moritz Bünemann, Linda Härmark, et al.. (2005). Phosducin-like Protein Regulates G-Protein βγ Folding by Interaction with Tailless Complex Polypeptide-1α. Journal of Biological Chemistry. 280(20). 20042–20050. 47 indexed citations
20.
Lindblom, Jonas, Ants Kask, Erik Hägg, et al.. (2002). Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacological Research. 45(2). 119–124. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florence van Hunsel Breakdown of academic impact, for papers by Shanthi Pal Breakdown of academic impact, for papers by Kees van Grootheest Breakdown of academic impact, for papers by Judith A. Racoosin Breakdown of academic impact, for papers by Janet Sultana Breakdown of academic impact, for papers by Tom Mjörndal Breakdown of academic impact, for papers by Lise Aagaard Breakdown of academic impact, for papers by Ronald D. Mann Breakdown of academic impact, for papers by Elliot G. Brown Breakdown of academic impact, for papers by Hitomi Teramachi
Rankless by CCL
2026